By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca shares rose on Thursday after the drugmaker said it could face a ...
"This marks Apple's worst annual performance in China," Canalys analyst Toby Zhu said. "Apple's premium market position faces multiple challenges: Huawei's continuous flagship releases, the ...